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Digalactoside (gal-1-4 gal) structures of the lipopolysaccharide (LPS) of Haemophilus influenzae are
implicated in virulence. A confounding factor is that tetranucleotide repeats within the lic2A, lgtC, and lex2
genes mediate phase-variable expression of the digalactosides. By deleting these repeats, we constructed
recombinant strains of RM153 constitutively expressing either one or two LPS digalactosides. Expression of
two digalactosides, rather than one, was associated with increased virulence of H. influenzae in vivo.
Lipopolysaccharide (LPS) is one of the major virulence de-
terminants of the human pathogen Haemophilus influenzae.
The number of hexoses and phosphate groups replacing the
triheptose (HepI to HepIII) backbone (Fig. 1) is variable
within any strain owing to high-frequency translational switch-
ing (phase variation) of LPS genes containing repeat tracts.
Phase-variable LPS genes include lic2A and lgtC, which are
involved in the assembly of gal-1-4 gal into the oligosaccha-
ride extensions from the conserved triheptose backbone (7,
10), and lex2, which is involved in completion of the HepI-
attached diglucoside acceptor for this digalactoside (Fig. 1) (4).
The investigation of the association between digalactoside ex-
pression on H. influenzae LPS and virulence has relied on the
monoclonal antibody (MAb) 4C4 for detecting the expression
of the digalactoside (1, 2, 12, 13). The findings from these
studies have been difficult to interpret because of the con-
founding factor of phase variation and the different numbers
and locations of the digalactoside on oligosaccharide exten-
sions in different strains (7, 17, 18).
Recently, it has been shown that MAb 4C4 binds digalacto-
sides that are part of the extensions from both HepI and HepII
of the triheptose LPS backbone (Fig. 1) (4, 5). A type b clinical
strain, RM153, used in previous virulence studies (9, 16), typ-
ically generates LPS molecules containing only four hexose
sugars (17), depending on whether lic2A, lgtC, or lex2 is out of
frame (4, 7, 10). This is in contrast to the related strain
RM7004, which has up to nine hexose sugars in its LPS due to
these three loci being predominantly in frame (Fig. 1). Know-
ing the LPS structure, the genes required for digalactoside
assembly, and the fact that tetranucleotide repeats mediate
phase variation, we constructed recombinant strains of RM153
in which variable expression of digalactosides was eliminated
by removing the repeat tracts located within each of these
genes. Briefly, two isogenic strains were constructed by trans-
formation (6) using appropriate chromosomal DNA or plas-
mid constructs in which the repeats had been deleted for lic2A
(8), lex2 (5), or lgtC. All three genes were constitutively ex-
pressed in the first strain, RM153lic2AtlgtClex2k, to fa-
cilitate expression of two digalactosides, while in the second
strain, RM153lic2AtlgtClex2k, lex2 was mutated such that
only a single digalactoside in the extension from HepII was
expressed (Fig. 1).
The strains were constructed as follows. An in-frame dele-
tion of the repeat tract of lic2A in RM153 was generated by
transformation with chromosomal DNA of a derivative of
RM7004 in which the 5-CAAT-3 repeats had been deleted
(8). Our construct differed from that of High and coworkers
(8) only in that the kanR antibiotic resistance cassette was
replaced with tetR. Into this strain (designated RM153lic2At),
we introduced an in-frame deletion of the repeats in lex2A by
transformation with pBlex25-GCAA-3k (4) and selection
for kanamycin resistance. The resultant strain, RM153lic2A
lex2k, was then transformed with pUClgtC5-GACA-
3lacZ, in which lacZ is fused to the 5 end of lgtC (Fig. 2C).
The disrupted lgtC gene of a lacZ-positive transformant of
RM153lic2Alex2k was rescued by transformation with pU-
ClgtC5-GACA-3, which carries an in-frame deletion of the
repeat tract of lgtC (Fig. 2B). Briefly, pUClgtC5-GACA-3
and pUClgtC5-GACA-3lacZ were created as follows. A
primer (LGTC3268R) was designed to include BglII and XhoI
sites followed by sequence complementary to sequence up-
stream of and including the initiation codon of lgtC (Fig. 2A).
Another primer, LGTCRPS1 (5-TCGAGATCTACGGACT
GTCAGTCAGACAATG-3), was designed to include a BglII
site followed by sequence immediately downstream of the re-
peat tract (Fig. 2A). Plasmid pBSHI, incorporating the region
encompassing lgtC of RM153 (Fig. 2A), was used as a source
of DNA. The region upstream of lgtC was amplified using
primers LGTC3268R (5-TGACTGACAGTCCGTCCGTCA
GATCTCGAGACGCGTTCATGAAATTATCTCTGATT-3)
and 6024J (5-TCGTAAGGAATAAGCGTG-3), and the
downstream region was amplified using primers LGTCRPS1
and T7 (Fig. 2A) (23). These fragments were cloned separately
and then fused using the BglII site and other appropriate
cloning sites in the vector plasmids to generate pUClgtC5-
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FIG. 1. Schematic representation of the structure of the fully extended LPS glycoforms of H. influenzae type b strains RM153 (17) and RM7004
(18). The LPS of strain RM7004 is similar in structure to that of RM153 except for an additional extension from the glucose attached to the first
heptose due to lex2A being in frame in this strain, as opposed to out of frame in RM153 (4). Represented in the LPS structure are the following:
Hep, LD-heptose; Glc, glucose; Gal, galactose; P, phosphate; ChoP, phosphorylcholine; PEA, phosphoethanolamine. A dotted line indicates the
substituents that are variably present. The places of action of lex2, lgtC, and lic2A are indicated. The proximal-to-distal heptoses are numbered I
to III accordingly.
FIG. 2. Schematic representation of plasmids pBSH1 (A), pUClgtC5-GACA-3 (B), and pUClgtC5-GACA-3lacZ (C). The primers and
their orientations and the restriction sites used to generate these constructs are shown. The open reading frames are represented by open boxes,
and initiation codons are represented by . The repeats of lgtC are shown as a vertically striped box.
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GACA-3 (Fig. 2B). Plasmid pUClgtC5-GACA-3lacZ was
created by replacing the XhoI-HindIII fragment of pU-
ClgtC5-GACA-3 with a XhoI-BamHI fragment of
pGZMCS (3), incorporating lacZ without an initiation
codon. Transformants constitutively expressing all three loci
were selected by their ability to react with MAb 4C4 and
designated RM153lic2AtlgtClex2k.
To obtain organisms expressing one digalactoside only, lex2
was disrupted in a strain in which lic2A and lgtC expression
was constitutive. This strain was constructed as follows.
RM153lic2At was transformed with a construct carrying lgtC
disrupted by kanR (10), and then lgtC expression was restored
by transformation with pUClgtC5-GACA-3 (Fig. 2B).
Transformants were selected for their restored ability to react
with MAb 4C4. Finally, lex2 was disrupted by transformation
with pDL2 (4), and transformants were selected by growth on
kanamycin. The resultant strain was designated RM153lic2A
tlgtClex2k. To confirm that the loci lacked repeats and were
maintained constitutively in frame in these strains, the repeat
region was amplified by PCR and sequenced using appropriate
primers. Note that a plus in a strain designation indicates that
the relevant gene lacks repeats and is therefore constitutively
expressed. A minus in a strain designation indicates a dis-
rupted gene that is not expressed. The designations “t” and “k”
indicate that selection for these genes was dependent upon
tetracycline or kanamycin antibiotic resistance cassettes, re-
spectively.
The magnitude of bacteremia for organisms expressing two
digalactosides, compared to that for organisms expressing one
digalactoside, was investigated in infant rats to assess the role
of gal-1-4 gal expression in intravascular survival in an in
vivo model.
Prior to mixed infection of infant rats, isogenic streptomy-
cin-resistant (Strr) mutants were obtained for RM153lic2A
tlgtClex2k and RM153lic2AtlgtClex2k. Use of these
mutants permitted discrimination between these strains follow-
ing challenge of the rats with a mixed inoculum by plating
blood cultures from infected animals onto medium with or
without streptomycin. The strains were transformed with chro-
mosomal DNA of a spontaneous Strr clone of RM153. The
resultant Strr isogenic strains showed no alteration in their LPS
compared to that of their progenitors and maintained the
deletions in the repeat tracts. Each of the four recombinant
strains showed no difference in growth rate (data not shown).
Twenty-eight 5-day-old Sprague-Dawley rats were each
given mixed infections by the intraperitoneal route (9): 15 rats
were inoculated with approximately 150 CFU of RM153lic2A
tlgtClex2k and 150 CFU of Strr RM153lic2AtlgtC
lex2k, while 13 received 150 CFU of each strain in which the
antibiotic resistance marker was switched so that the former
strain carrying the Strr marker was now streptomycin sensitive.
Forty-eight hours after inoculation, significantly higher num-
bers of bacteria expressing two digalactosides than of the sin-
gle-digalactoside-expressing strain were recovered from tail
vein blood from infant rats, as determined by the nonparamet-
ric Mann-Whitney U test (P value, 0.0287) (Table 1). The
paired data in Table 1 were also used to derive a competition
ratio for bacteria expressing two digalactosides versus one di-
galactoside (ratio determined by dividing the number of CFU
of strain RM153lic2AtlgtClex2k by that of strain
RM153lic2AtlgtClex2k). The average ratio was higher
when the single-digalactoside-expressing strain was streptomy-
cin resistant, although this antibiotic resistance mutation could
be associated with a small fitness deficit. However, as the
average ratio was greater than 1 in both groups of animals, this
TABLE 1. Numbers of CFU of strains RM153lic2AtlgtClex2k
and RM153lic2AtlgtClex2k per ml of blood extracted
from the tail vein of rats
Rat






1 4.00  105 3.20  105a 1.25
2 7.67  107 8.20  106a 9.35
3 2.54  107 1.48  106a 17.16
4 9.15  107 1.23  107a 7.44
5 1.60  105 4.00  104a 4.00
6 1.33  107 2.04  106a 6.52
7 4.53  106 1.08  105a 41.94
8 1.24  106 4.00  104a 31.00
9 5.00  106 5.60  105a 8.93
10 1.27  107 7.60  105a 16.71
11 1.12  106 1.20  105a 9.33
12 1.12  106 4  104a 28.00
13 6.14  104 1.25  105a 0.49
14 9.60  105 4.80  105a 2.00
15 2.40  105 6.12  104a 3.92
16 1.60  104a 1.35  105 0.12
17 8.40  105a 6.00  105 1.40
18 3.28  106a 3.20  106 1.03
19 4.00  105a 2.00  105 2.00
20 3.64  104a 1.03  105 0.35
21 2.26  105a 4.44  104 5.09
22 4.22  105a 1.06  106 0.40
23 2.00  105a 1.60  105 1.25
24 1.24  106a 6.40  105 1.94
25 3.27  105a 6.40  104 5.11
26 2.64  106a 4.64  106 0.57
27 4  104a 7.60  105 0.05
28 1.42  107a 5.35  107 0.27
a Strains carrying the streptomycin resistance gene.
b Competition ratio, value obtained by dividing the number of CFU of strain
RM153lic2AtlgtClex2k by that for strain RM153lic2AtlgtClex2k.
TABLE 2. Negative-ion electrospray-mass spectrometry analysis
and proposed composition for the major components of
O-deacylated LPS of strain RM153lic2AtlgtClex2k
Mol wt Compositiona Relativeabundance
2,601 Lipid A, Kdo-P, 3Hep, PEA, 4Hex 0.20
2,724 Lipid A, Kdo-PPEA, 3Hep, PEA, 4Hex 0.15
2,763 Lipid A, Kdo-P, 3Hep, PEA, 5Hex 1.00
2,886 Lipid A, Kdo-PPEA, 3Hep, PEA, 5Hex 0.80
2,925 Lipid A, Kdo-P, 3Hep, PEA, 6Hex 0.40
3,048 Lipid A, Kdo-PPEA, 3Hep, PEA, 6Hex 0.40
3,087 Lipid A, Kdo-P, 3Hep, PEA, 7Hex 0.15
3,210 Lipid A, Kdo-PPEA, 3Hep, PEA, 7Hex 0.10
3,249 Lipid A, Kdo-P, 3Hep, PEA, 8Hex 0.07
3,372 Lipid A, Kdo-PPEA, 3Hep, PEA, 8Hex 0.08
3,411 Lipid A, Kdo-P, 3Hep, PEA, 9Hex 0.03
3,534 Lipid A, Kdo-PPEA, 3Hep, PEA, 9Hex 0.02
a Kdo-P, 2-keto-3-deoxyoctulosonic acid replaced by monophosphate; Hep,
LD-heptose; PEA, phosphoethanolamine; Hex, hexose; Kdo-PPEA, 2-keto-3-
deoxyoctulosonic acid replaced by pyrophosphoethanolamine.
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result provides further evidence that increased digalactoside
expression leads to enhanced virulence.
In order to substantiate the data from the animal studies, we
investigated the LPS expression patterns of the two isogenic
test strains used to infect rats. These strains had been cultured
in 1% galactose, which was previously shown to encourage the
incorporation of galactose into the LPS (16).
First, the reactivity of colonies of the test strains was inves-
tigated using MAb 4C4 (21). RM153lic2AtlgtClex2k
showed the reactive (R) phenotype only, suggesting the expres-
sion of a single digalactoside, while RM153lic2AtlgtC
lex2k demonstrated the strongly reacting (S) phenotype only,
indicative of the expression of two digalactosides (Fig. 3A) as
documented for RM7004 (4).
Second, duplicate sodium dodecyl sulfate-polyacrylamide
gels were run with whole-cell lysates (14, 22). One gel was
stained with silver (20), while the other was blotted onto a
membrane and reacted with MAb 4C4 (24). The predominant
band of LPS from RM153lic2AtlgtClex2k showed migra-
tion equivalent to that expected for glycoforms comprising six
hexose sugars and showed staining, albeit weak, with MAb
4C4, thus confirming the presence of a single digalactoside
(Fig. 3). Strain RM153lic2AtlgtClex2k showed additional
bands; each incremental band size is considered to represent
an additional hexose (9). A band corresponding to the pres-
ence of nine hexose sugars and reactive with MAb 4C4 was
detected for RM153lic2AtlgtClex2k, as for RM7004,
which typically contains each of the three loci in frame and
FIG. 3. Analysis of the LPS of strains RM153, RM153lic2AtlgtClex2k and RM153lic2AtlgtClex2k by immunoblotting and electro-
phoresis. (A) Colonies of strains (i) RM153, (ii) RM153lic2AtlgtClex2k, and (iii) RM153lic2AtlgtClex2k were tranferred to nitrocel-
lulose membranes and incubated with MAb 4C4 (21). Intermediate reacting (R), strong (S,) and negative or off (O) MAb 4C4 phenotypes are
indicated. (B and C) PAGE analysis of bacterial lysates (22) visualized by silver staining (20) (B) and by transfer to nitrocellulose for incubation
with MAb 4C4 (24) (C) from H. influenzae strains grown in the absence and presence (GAL) of galactose. Lanes 1 and 10, standard protein
markers; lanes 2 and 3, RM153; lanes 4 and 5, RM153lic2AtlgtClex2k; lanes 6 and 7, RM153lic2AtlgtClex2k; lanes 8 and 9, RM7004.
The number of hexose sugars predicted to be present in each LPS glycoform (band) represented is indicated.
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expresses two digalactoside-containing oligosaccharides (Fig.
3) (18).
Finally, the presence of nine hexose sugars in RM153lic2A
tlgtClex2k was confirmed by electrospray-ionization mass
spectrometry (Table 2) (15). Compositional sugar analysis (15)
indicated a 5:4 ratio of galactose to glucose, analogous to the
fully extended glycoform of RM7004.
In conclusion, variants capable of expressing two rather than
one digalactoside were more virulent in vivo. These data pro-
vide strong indications of the importance of the gal-1-4 gal
digalactoside structure of LPS in virulence, but some caveats
must be considered in interpreting these results. First, the
relevance of findings from an infant rat model for humans is of
course open to question, especially since host cells in the rat
express digalactosides in which the galactose linkage is 1-3
(19). In contrast, humans express an 1-4 digalactoside iden-
tical to that found on the LPS of H. influenzae. Another im-
portant potentially confounding factor is the extent of LPS
sialylation. We cannot exclude the possibility that the differ-
ences in virulence observed could be attributed, at least in part,
to differences in sialylated LPS glycoforms (11), or indeed
other unrecognized but relevant and subtle differences in LPS
structure that are independent of digalactoside expression.
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